Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New PhRMA CEO: Drug Costs Must Be Viewed In Context

This article was originally published in Scrip

Executive Summary

With the biopharmaceutical industry frequently coming under attack over the past year about the high prices of certain medicines – decades-old drugs with significantly hiked up prices and expensive new innovative medications for hepatitis C virus (HCV) and severely uncontrolled cholesterol – the new head of the Pharmaceutical Research and Manufacturers of America (PhRMA) urged policymakers and patients to consider the costs of those products in context.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts